Tag: life science
Pekka Simula joins Sartar’s board of directors
26.9.2018
Sartar strengthens the board of directors. CEO of Herantis Pharma, Pekka Simula, has been appointed as a new member to the Sartar Therapeutics board of directors.
Sartar was awarded a U.S. patent
16.10.2017
Sartar was awarded a U.S. patent for use of anagrelide in cancer therapy.